FK 888

Discontinued Product

FK 888 (Cat. No. 0696) has been withdrawn from sale for commercial reasons.
Cat.No. 0696 - FK 888 | C36H36N4O4 | CAS No. 138449-07-7
Description: Selective NK1 antagonist
Datasheet
Citations
Reviews
Literature

Biological Activity

A potent antagonist at NK1 receptors.

Technical Data

M. Wt 588.71
Formula C36H36N4O4
Storage Store at RT
CAS Number 138449-07-7

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service

References

References are publications that support the biological activity of the product.

Fujii et al (1992) Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist. FK888. Br.J.Pharmacol. 107 785 PMID: 1282073

Goso et al (1994) Comparison of tachykinin NK1 receptors in human IM9 and U373MG cells, using antagonist (FK 888, (±)-CP-96,345 and RP67580) binding. Eur.J.Pharmacol. 254 221 PMID: 7516885

Wang et al (1994) Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist. Br.J.Pharmacol. 111 1342 PMID: 7518299

View Related Products by Target

View Related Products by Product Action

View all NK1 Receptor Antagonists

Keywords: FK 888, FK 888 supplier, selective, NK1, receptors, antagonists, tachykinins, neurokinins, Receptor, 0696, Tocris Bioscience

Citations for FK 888

Citations are publications that use Tocris products.

Currently there are no citations for FK 888.

Reviews for FK 888

There are currently no reviews for this product. Be the first to review FK 888 and earn rewards!

Have you used FK 888?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Secretin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Pain

Pain Research Product Guide

A collection of over 250 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling
Peptide Hormone Receptors

Peptide Hormone Receptors Product Listing

A collection of over 200 products for peptide hormone receptors, the listing includes research tools for the study of:

  • Anterior Pituitary Regulation
  • Blood Pressure Regulation
  • Feeding and Appetite Regulation
  • Glucose Regulation
  • Peptide Hormone Processing
Peptides Involved in Appetite Modulation

Peptides Involved in Appetite Modulation Scientific Review

Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.

Cardiovascular

Cardiovascular Poster

Cardiovascular disease remains one of the major causes of morbidity and mortality in the Western world and therefore this therapeutic area continues to be of great interest to researchers. This poster highlights the key GPCRs regulating vascular reactivity.

Depression

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.